High-dose-rate interstitial brachytherapy in the management of carcinoma of the uterine cervix and other gynecologic malignancies.
Artículo
en Inglés
| IMSEAR
| ID: sea-39935
ABSTRACT
OBJECTIVE:
To report technique and experience of high-dose-rate (HDR) interstitial brachytherapy in the treatment of cervical carcinoma and other gynecologic malignancies. MATERIAL ANDMETHOD:
Between April 2003 and October 2004, ten patients (7-cervical carcinoma, 3-vaginal stump carcinoma) were treated with interstitial implant. Indications for implant include previous hysterectomy and previous pelvic radiation. Patient characteristics, implant technique, and initial outcomes were reported.RESULTS:
Transperineal interstitial implant was performed using fluoroscopy-guided technique. Brachytherapy dose/fraction ranged from 500-750 cGy for 1 to 6 fractions. Combined external beam radiation was given in 8 patients. After 5-21 months follow-up, all the patients were alive. Local control was achieved in 9 patients. One patient had persistent disease at the implant site. No acute complication from the procedure or serious late complication was observed.CONCLUSION:
Interstitial implant can be a treatment option in patients with gynecologic malignancies who have limitations with standard intracavitary insertion. This technique is feasible, providing good local control without serious complications. However, long-term follow-up is needed.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Dosis de Radiación
/
Radioisótopos
/
Anciano de 80 o más Años
/
Braquiterapia
/
Anciano
/
Femenino
/
Humanos
/
Carcinoma
/
Neoplasias del Cuello Uterino
/
Cuello del Útero
Tipo de estudio:
Estudio observacional
Límite:
Aged80
Idioma:
Inglés
Año:
2005
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS